Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,683 | 614 | 97.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $321.83 | 22 | 2.9% |
| Education | $8.44 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $979.90 | 47 | $0 (2024) |
| Biogen, Inc. | $824.51 | 42 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $803.40 | 55 | $0 (2024) |
| SK Life Science, Inc. | $795.79 | 52 | $0 (2024) |
| UCB, Inc. | $615.98 | 48 | $0 (2024) |
| Lundbeck LLC | $494.85 | 28 | $0 (2024) |
| ACADIA Pharmaceuticals Inc | $448.49 | 28 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $443.93 | 28 | $0 (2024) |
| Acorda Therapeutics, Inc | $392.40 | 26 | $0 (2023) |
| PFIZER INC. | $357.39 | 30 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,413 | 132 | ABBVIE INC. ($412.86) |
| 2023 | $2,665 | 163 | AbbVie Inc. ($448.94) |
| 2022 | $1,550 | 93 | SK Life Science, Inc. ($370.78) |
| 2021 | $1,181 | 75 | Biohaven Pharmaceuticals, Inc. ($157.37) |
| 2020 | $692.03 | 37 | Greenwich Biosciences, Inc. ($84.73) |
| 2019 | $746.02 | 38 | W. L. Gore & Associates, Inc. ($137.66) |
| 2018 | $744.13 | 42 | Acorda Therapeutics, Inc ($168.86) |
| 2017 | $1,022 | 57 | Teva Pharmaceuticals USA, Inc. ($178.46) |
All Payment Transactions
637 individual payment records from CMS Open Payments — Page 1 of 26
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $34.01 | General |
| 12/20/2024 | Genentech USA, Inc. | Ocrevus (Biological), Ocrevus Zunovo | Food and Beverage | In-kind items and services | $15.84 | General |
| Category: Immunology | ||||||
| 12/06/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $10.29 | General |
| Category: NEUROLOGY | ||||||
| 12/06/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $2.14 | General |
| Category: NEUROLOGY | ||||||
| 12/05/2024 | Vanda Pharmaceuticals Inc. | PONVORY (Drug) | Food and Beverage | In-kind items and services | $28.26 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
| 11/25/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $7.70 | General |
| Category: Neurology | ||||||
| 11/23/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $7.87 | General |
| Category: Neurology | ||||||
| 11/23/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $5.12 | General |
| Category: Neurology | ||||||
| 11/21/2024 | Amneal Pharmaceuticals LLC | CREXONT (Drug) | Food and Beverage | In-kind items and services | $13.27 | General |
| Category: NEUROLOGY | ||||||
| 11/20/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $11.09 | General |
| Category: NEUROSCIENCE | ||||||
| 11/19/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $18.26 | General |
| Category: PAIN | ||||||
| 11/14/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $20.86 | General |
| Category: Neurology | ||||||
| 11/14/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $1.49 | General |
| Category: Neurology | ||||||
| 11/13/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $19.82 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/13/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $17.43 | General |
| Category: PAIN | ||||||
| 10/31/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $12.80 | General |
| Category: NEUROLOGY | ||||||
| 10/29/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $17.22 | General |
| Category: NEUROSCIENCE | ||||||
| 10/25/2024 | Vanda Pharmaceuticals Inc. | PONVORY (Drug) | Food and Beverage | In-kind items and services | $28.51 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
| 10/24/2024 | Vanda Pharmaceuticals Inc. | PONVORY (Drug) | Food and Beverage | In-kind items and services | $28.51 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
| 10/23/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $20.24 | General |
| Category: NEUROSCIENCE | ||||||
| 10/17/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $15.06 | General |
| Category: NEUROSCIENCE | ||||||
| 10/17/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $7.06 | General |
| Category: NEUROSCIENCE | ||||||
| 10/15/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $17.37 | General |
| Category: NEUROLOGY | ||||||
| 10/09/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $18.74 | General |
| Category: NEUROSCIENCE | ||||||
| 10/07/2024 | Lilly USA, LLC | AMYVID (Drug), KISUNLA | Food and Beverage | In-kind items and services | $17.12 | General |
| Category: Neuroscience | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 1,173 | 1,848 | $467,236 | $154,072 |
| 2022 | 8 | 1,208 | 1,907 | $510,688 | $169,864 |
| 2021 | 9 | 1,012 | 1,640 | $421,601 | $147,023 |
| 2020 | 10 | 805 | 1,345 | $329,665 | $115,129 |
All Medicare Procedures & Services
50 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 209 | 572 | $125,840 | $49,773 | 39.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 215 | 367 | $99,090 | $30,051 | 30.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 210 | 223 | $91,430 | $28,343 | 31.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 104 | 116 | $42,920 | $13,327 | 31.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 89 | 89 | $40,940 | $11,971 | 29.2% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2023 | 123 | 129 | $15,480 | $5,230 | 33.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 29 | 29 | $13,340 | $3,753 | 28.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 30 | 35 | $12,950 | $3,734 | 28.8% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Facility | 2023 | 79 | 80 | $9,680 | $3,278 | 33.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 23 | 26 | $7,020 | $1,888 | 26.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 18 | 18 | $3,420 | $1,068 | 31.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 11 | 16 | $2,400 | $944.16 | 39.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 16 | 70 | $2,100 | $637.45 | 30.4% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 17 | 78 | $626.00 | $75.12 | 12.0% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 236 | 710 | $156,200 | $53,983 | 34.6% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 221 | 228 | $93,600 | $33,276 | 35.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 172 | 278 | $75,060 | $23,639 | 31.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 124 | 169 | $62,530 | $21,206 | 33.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 108 | 108 | $49,680 | $15,166 | 30.5% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2022 | 118 | 121 | $14,520 | $5,047 | 34.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 35 | 45 | $16,650 | $4,734 | 28.4% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Facility | 2022 | 106 | 107 | $12,947 | $4,560 | 35.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 35 | 35 | $16,100 | $4,556 | 28.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 39 | 49 | $13,230 | $3,630 | 27.4% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2022 | 14 | 57 | $171.00 | $65.79 | 38.5% |
About Dr. Maryanhthu Do, D.O
Dr. Maryanhthu Do, D.O is a Neurology healthcare provider based in Munster, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/08/2006. The National Provider Identifier (NPI) number assigned to this provider is 1912917659.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Maryanhthu Do, D.O has received a total of $11,013 in payments from pharmaceutical and medical device companies, with $2,413 received in 2024. These payments were reported across 637 transactions from 59 companies. The most common payment nature is "Food and Beverage" ($10,683).
As a Medicare-enrolled provider, Do has provided services to 4,198 Medicare beneficiaries, totaling 6,740 services with total Medicare billing of $586,087. Data is available for 4 years (2020–2023), covering 50 distinct procedure/service records.
Practice Information
- Specialty Neurology
- Other Specialties Neurology
- Location Munster, IN
- Active Since 08/08/2006
- Last Updated 07/10/2019
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1912917659
Products in Payments
- NURTEC ODT (Drug) $634.11
- Briviact (Drug) $585.07
- UBRELVY (Drug) $556.02
- TYSABRI (Biological) $454.50
- NUPLAZID (Drug) $448.49
- KESIMPTA (Drug) $447.94
- VYEPTI (Biological) $385.97
- VALTOCO (Drug) $311.30
- GILENYA (Drug) $282.54
- Aimovig (Biological) $269.29
- AMPYRA (Drug) $210.98
- QULIPTA (Drug) $203.30
- EMGALITY (Drug) $198.61
- Rebif (Biological) $190.13
- Epidiolex (Drug) $187.41
- INBRIJA (Drug) $181.42
- EPIDIOLEX (Drug) $178.40
- AVONEX (Biological) $175.12
- AJOVY (Biological) $169.50
- LUMRYZ (Drug) $159.10
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Munster
Dr. Ender Akan, M.d, M.D
Neurology — Payments: $262,053
Dr. Andrea Deleo, D.o., M.s.e, D.O., M.S.E
Neurology — Payments: $51,436
Dr. Shaila Gupta, D.o, D.O
Neurology — Payments: $18,511
Dr. Aamir Badruddin, M.d, M.D
Neurology — Payments: $3,937
Dr. David Rozenfeld, M.d, M.D
Neurology — Payments: $3,672
Dr. Steven Bayer, D.o, D.O
Neurology — Payments: $2,863